VaxiFlu-4 is an inactivated influenza vaccine (split virion, tetravalent) developed to provide active immunization against seasonal influenza. Each 0.5 ml pre-filled syringe contains split virion antigens from four influenza virus strains, as recommended for the 2024–2025 flu season. The tetravalent formulation offers broader coverage by including two influenza A strains and two influenza B strains. It is administered intramuscularly and is suitable for adults as well as children aged 6 months and above. VaxiFlu-4 stimulates the immune system to recognize influenza viruses, helping prevent flu infection and its associated complications. Updated annually to align with WHO recommendations, this vaccine ensures effective protection during the flu season.
Specifications
- Service at Doorstep : FREE Home vaccination availability
- Cold Chain Compliance : Maintains 2-8°C
- VACCINATION KIT : AVAILABLE
- VACCINATION OFFICER : YES